Opdualag (nivolumab and relatlimab-rmbw) injection, 240 mg and 80 mg/20 mL (12mg and 4mg/mL),Single Dose Vial, RX Only, Bristol-Myers Squibb Company, Princeton, NJ 08543, NDC 0003-7125-11
Published October 29, 2025 · Recall initiated: October 21, 2025
Summary
FDA records drug Class II recall D-0097-2026, published October 29, 2025 and initiated October 21, 2025. Recalling firm: Bristol-Myers Squibb Company; Status: Ongoing; Reported quantity: 12,778 total vials; Lot: Lot: 033A23B, Expiry: 4/30/2026. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.
Status when published: Ongoing — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.
What's the hazard
Lack of Assurance of Sterility.
What to do
Voluntary: Firm initiated · Letter
Get an email if OPDUALAG has another recall
Free. We only write when there's a new recall that matches. Unsubscribe in one click.
Recall details
- Brand
- OPDUALAG
- Manufacturer
- Bristol-Myers Squibb Company
- Distributor
- Nationwide in the USA
- Lot
- Lot: 033A23B, Expiry: 4/30/2026
- Risk classification
- Class II
- Area (FDA)
- drug
- Country
- United States
Related recalls
- FDANiacin Extended-release Tablets, USP, 1,000 mg, Rx Only, 90 Tablets per bottle, Distributed by: LannettOctober 29, 2025
- FDATaoscare Motion Sickness Patches 36-count box, Henan Xinyongtal Medical Technology., Ltd., Address: he nanOctober 29, 2025
- FDAZICAM" MEDICATED FRUIT DROPS ELDERBERRY FLAVOR, 25-drops per bottle, Distributed by: Church & Dwight Co., Inc.October 29, 2025
- FDAJumbo Meat Ball Sub; Net Weight: 8.9oz; Product Code: Fresh Thru 10-15-25, 10/16/2025, 10/20/2025 In clearOctober 29, 2025
- FDABupropion Hydrochloride Extended-Release Tablets USP (XL), 300 mg, 30-count bottles, Rx Only, Mfd. by: GravitiOctober 29, 2025
- FDAFloria Dried Apricots, 200 Gram packages, 40 packages per case .October 29, 2025
Questions about this recall
Was Opdualag (nivolumab and relatlimab-rmbw) injection, 240 mg and 80 mg/20 mL (12mg and 4mg/mL),Single Dose Vial, RX Only, Bristol-Myers Squibb Company, Princeton, NJ 08543, NDC 0003-7125-11 recalled?
Yes. FDA published recall D-0097-2026 on October 29, 2025. Reported hazard: Lack of Assurance of Sterility.
What should I do if I have this product?
Voluntary: Firm initiated · Letter
How do I know if my unit is part of the recall?
Compare your product details with the notice. Brand: OPDUALAG.